TURNSTONE BIOLOGICS
Live / Registered — Registered (as of 06 Oct 2020)
What this means for you
Registered since 06 Oct 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86456193
- Registration number
- 6166542
- Mark type
- Stylized text
- Filed
- 17 Nov 2014
- Published for opposition
- 21 Jul 2020
- Registered
- 06 Oct 2020
- Attorney of record
- Tye Biasco
Goods and services
- Class 005 — Pharmaceuticals: Oncolytic viruses, namely, oncolytic vaccines, viral vectors for gene delivery or protein expression from the gene; pharmaceutical compounds and products for the prevention and treatment of cancer and infectious diseases, namely, antibodies in the field of cancer and infectious diseases, proteins and peptides products for the prevention and treatment of cancer and infectious diseases; pharmaceutical and vaccine products, namely, human vaccine preparations for the prevention and treatment of cancer and infectious diseases
- Class 042 — Scientific and technological services: Research and development in connection with oncolytic viruses and oncolytic vaccines, and viral vectors
Owner
- Turnstone Biologics Inc., Toronto, Ontario, CA
- Turnstone Biologics Inc., Toronto, Ontario, CA
- Turnstone Biologics Inc., Toronto, Ontario, CA
Prosecution history
- 06 Oct 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Oct 2020 — REGISTERED-PRINCIPAL REGISTER
- 21 Jul 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jul 2020 — PUBLISHED FOR OPPOSITION
- 01 Jul 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Jun 2020 — ELECTRONIC RECORD REVIEW COMPLETE
- 12 Jun 2020 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 04 Jun 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Jun 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Jun 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Jun 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 Dec 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 04 Dec 2019 — NON-FINAL ACTION E-MAILED
- 04 Dec 2019 — NON-FINAL ACTION WRITTEN
- 29 Oct 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED